LoginRegister
    Biocon Q3 profit zooms twofold to Rs 217 croreBiocon Q3 profit zooms twofold to Rs 217 crore
    Bristol Myers pulls FDA application for Opdivo combination in lung cancerBristol Myers pulls FDA application for Opdivo combination in lung cancer
    Not for profit to offer 20 generic drugs in 2019 to alleviate shortagesNot for profit to offer 20 generic drugs in 2019 to alleviate shortages
    Polyplastics develops new DURACON(R) POM PM Series for medical, healthcare industryPolyplastics develops new DURACON(R) POM PM Series for medical, healthcare industry
    Bar Code to be made mandatory for public procurement of drugsBar Code to be made mandatory for public procurement of drugs
    Glenmark gets USFDA nod for Topiramate extended release capsulesGlenmark gets USFDA nod for Topiramate extended release capsules
    2019 HITLAB Innovators Summit: Empowering digital health innovation for over billion lives in India2019 HITLAB Innovators Summit: Empowering digital health innovation for over billion lives in India
    U.S. insulin costs per patient nearly doubled from 2012 to 2016: studyU.S. insulin costs per patient nearly doubled from 2012 to 2016: study
    Natco Pharma ventures into agrichemical space, sets up Rs 100 crore facility in APNatco Pharma ventures into agrichemical space, sets up Rs 100 crore facility in AP
    DOP directs NPPA to fix retail price of Baclofen Oral Solution based on Sun Pharma ComplaintDOP directs NPPA to fix retail price of Baclofen Oral Solution based on Sun Pharma Complaint
    Dr Reddys launches Propofol Injectable Emulsion in US marketDr Reddy's launches Propofol Injectable Emulsion in US market
    mfine targets to connect 1000 hospitals,15 cities by next 3 yearsmfine targets to connect 1000 hospitals,15 cities by next 3 years
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X